Flatirons Solutions Joins TELEO Capital
9.11.2021 19:02:00 EET | Business Wire | Press release
Flatirons Solutions, the global leader in technical content management solutions for aviation and defense, is proud to announce its acquisition and investment by TELEO Capital Management.
“We are thrilled with this new chapter in our companies’ futures. TELEO and Flatirons share common values, especially when it comes to caring about our customers and employees. This partnership and investment expand our capacity to serve our airline, aerospace, and defense customers and reaffirms the success of the product restructuring and consolidation we have accomplished over the past two years,” said Flatirons Solutions CEO, Stéphane Labadie.
“Many new innovations will be enabled with this partnership, furthering our products’ leadership position in the airline, aerospace, and defense markets. By mid-2022, we will complete the launch of our new SaaS-based product suite as we work closely with two of the world’s largest airlines as inaugural customers of our fully cloud-based platform,” continued Labadie. The solution extends prior Flatirons content management functionality, providing the industry with access to a fully hosted solution for managing the digital publication and rendering of maintenance manuals, work cards, and other aviation technical documents for airframe, flight operations, and engine manuals vital to their success.
“We looked at Flatirons’ innovation potential, execution, quality of staff and top-tier customers, as well as their accomplishments over the past three years. With their 20 years of leadership in the industry, we knew that they fit perfectly in our expanding aviation portfolio,” said Matt Scholl, TELEO Operating Partner.
Read the entire Message from CEO Stéphane Labadie here.
About Flatirons Solutions
Flatirons Solutions® (www.FlatironsSolutions.com) provides software and services solutions for technical content management. For more than 20 years, it has served global Fortune 1000 customers in the airline, aerospace, and defense industries. Its leading solutions enable organizations to simply and efficiently deliver the right technical information, in the right format, at the right time, to the right people—Turning Content into Knowledge®. Flatirons operates from offices in India, throughout Europe, and the United States and is headquartered in Boulder, CO.
About TELEO Capital Management
TELEO Capital Management (www.teleocapital.com) is a lower middle market private equity firm that looks to invest in opportunities where its strategic thought, operational resources, and capital base empower management to perform and execute their business plan. TELEO brings a successful track record of executing corporate carve-outs, recapitalizing broken balance sheets, acquiring founder-owned companies, as well as buy and build strategies for our portfolio companies. TELEO targets opportunities in the technology and software, healthcare IT, business services, and industrial sectors. TELEO is headquartered in Boise, Idaho.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005407/en/
Contact information
Joe Mihalik
+1-303-748-0671
joe.mihalik@flatironssolutions.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways to Announce First Quarter 2026 Financial Results on May 13, 20266.5.2026 13:30:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the first quarter ended March 31, 2026, and provide an update on recent developments, on May 13, 2026. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on May 13, 2026. A live webcast of the call will be available on the Compass Pathways website at: https://events.q4inc.com/attendee/144892287. The webcast will be archived for 30 days. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)6.5.2026 13:25:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to thirteen newly hired non-executive employees. The equity awards were granted on May 1, 2026 and consisted of options to purchase an aggregate of 125,335 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 59,625 shares. The options have an exercise price per share equal to $9.01, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
AB InBev Wins Cannes Lions Creative Marketer of the Year for an Unprecedented Third Time6.5.2026 13:03:00 EEST | Press release
The Cannes Lions International Festival of Creativity has announced AB InBev (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD) as the 2026 Creative Marketer of the Year. The honorary accolade is presented to a marketer that has amassed a body of iconic, Lion-winning work over a sustained period of time. AB InBev’s continued commitment to using creativity as a growth lever across its portfolio resulted in it winning an impressive 37 Lions at last year’s Festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260506536538/en/ AB InBev is the first company in Cannes Lions’ history to be honoured with the award for a third time. Since 2021 the global brewer has embarked on a journey of inorganic to organic growth, betting on creativity as a key competitive advantage that has contributed to strong performance and increased revenues. About the honour, Simon Cook, CEO, LIONS, said: “AB InBev has embedded creativity into how it operates
Aircall Acquires Vogent to Advance Its AI Voice Agent Built Natively into Business Phones6.5.2026 13:03:00 EEST | Press release
Aircall, the AI-powered customer communications platform trusted by more than 22,000 businesses worldwide, today announced the acquisition of Vogent, an AI voice agent company. The acquisition adds a new layer of specialized voice AI technology to Aircall’s platform – strengthening the technology behind Aircall’s AI Voice Agent and moving it from already great to best-in-class. While AI agents' chat or email based communication channels have exploded in popularity, voice is its own discipline – with unique demands around timing, interruption handling, call flows, and production reliability. Voice channel also comes with the highest expectations from customers, further putting scrutiny around the readiness of the technology. For many businesses deploying AI voice agents, the experience has not lived up to the hype. With Vogent, Aircall enhances its AI Voice Agents with a deeper set of specialized AI technologies, including advanced speech models, more reliable turn-taking, and higher pr
BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates6.5.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the first quarter of 2026. John V. Oyler, Co-Founder, Chairman, and CEO, BeOne, said: “These strong first-quarter results reinforce BeOne’s continued growth as a global oncology leader, driven by disciplined commercial execution, and underpinned by our established hematology leadership, and an impressive, rapidly emerging solid tumor pipeline. The sustained competitive advantages of our global superhighway for clinical development and manufacturing are now clear. BRUKINSA has firmly established itself as the foundational, best-in-class BTK inhibitor with unmatched long-term efficacy and safety data for the treatment of CLL and as the only BTKi with proven efficacy superiority over ibrutinib which has resulted in clear global revenue leadership. The fixed-duration combination of sonrotoclax, a foundational, next-generation BCL2 inhibitor,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom